Manufacturers Life Insurance Company, The Regeneron Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 356,410 shares of REGN stock, worth $250 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
356,410
Previous 338,044
5.43%
Holding current value
$250 Million
Previous $355 Million
28.56%
% of portfolio
0.23%
Previous 0.33%
Shares
34 transactions
Others Institutions Holding REGN
# of Institutions
1,490Shares Held
85.7MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.53 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.94 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.96 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.4 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.33 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $75.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...